Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Weilenmann

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Revue Medicale De La Suisse Romande|April 28, 1999
[The anti-leukotrienes: a new class of drugs to integrate into the therapeutic strategy of asthma]J M Fellrath, P Leuenberger, C Weilenmann, et al.
Revue Medicale De La Suisse Romande|April 28, 1999
[Inhaled steroids effect on bones]C Weilenmann, O Lamy, J M Fellrath, et al.
Allergy|December 13, 2006
Allergy to betalactam antibiotics in children: a prospective follow-up study in retreated children after negative responses in skin and challenge testsC Ponvert, C Weilenmann, J Wassenberg, et al.
Parassitologia|March 4, 2000
Plasmodium falciparum CS C-terminal fragment: preclinical evaluation and phase I clinical studiesM A Roggero, C Weilenmann, A Bonelo, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Revue Medicale De La Suisse Romande|April 28, 1999
[The anti-leukotrienes: a new class of drugs to integrate into the therapeutic strategy of asthma]J M Fellrath, P Leuenberger, C Weilenmann, et al.
Revue Medicale De La Suisse Romande|April 28, 1999
[Inhaled steroids effect on bones]C Weilenmann, O Lamy, J M Fellrath, et al.
Allergy|December 13, 2006
Allergy to betalactam antibiotics in children: a prospective follow-up study in retreated children after negative responses in skin and challenge testsC Ponvert, C Weilenmann, J Wassenberg, et al.
Parassitologia|March 4, 2000
Plasmodium falciparum CS C-terminal fragment: preclinical evaluation and phase I clinical studiesM A Roggero, C Weilenmann, A Bonelo, et al.
Pageof 1